临床和口服兼容的制剂生产的靶向DDX5（p68）的分子胶FL118产品对人类癌症显示出低毒性但高效能。
Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer.
作者信息
Ling Xiang, Wu Wenjie, Yan Li, Curtin Leslie, Farrauto Melanie M, Sexton Sandra, Jamroze Anmbreen, Yu Changjun, Fountzilas Christos, Tang Dean G, Li Fengzhi
机构信息
Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, 14263, USA.
Canget BioTekpharma LLC, Buffalo, New York, 14203, USA.
出版信息
J Pharm Anal. 2024 Nov;14(11):101001. doi: 10.1016/j.jpha.2024.101001. Epub 2024 May 13.
Abstract
Image 1.
摘要
图1。
Zotero 插件